title: [Multimodal therapy of Miller-Fisher syndrome. Possible benefit of cerebrospinal fluid filtration].
abstract: A 47 year old male patient with Miller-Fisher-syndrome did not respond to treatment with plasmapheresis and intravenous high dose 7 S immune globulins. Only cerebrospinal fluid pheresis, administered as final alternative, lead to definite improvement and cure.
authors.affiliation: Univ.-Klinik für Neurologie, Innsbruck, Osterreich.
authors.forename: B
authors.initials: B
authors.lastname: Pfausler
authors.forename: G
authors.initials: G
authors.lastname: Grubwieser
authors.forename: A
authors.initials: A
authors.lastname: Auckenthaler
authors.forename: H
authors.initials: H
authors.lastname: Rogenhofer
authors.forename: E
authors.initials: E
authors.lastname: Schmutzhard
mesh_terms: D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000134:cerebrospinal fluid*; D008297:Male; D008875:Middle Aged; D019846:Miller Fisher Syndrome / Q000134:cerebrospinal fluid / Q000276:immunology / Q000628:therapy*; D009460:Neurologic Examination; D010956:Plasmapheresis; D017211:Treatment Failure; D014462:Ultrafiltration
chemical_list: D007074:Immunoglobulin G
vernacular_title: Multimodale Therapie eines Miller-Fisher-Syndroms. Der mögliche Nutzen der Liquor-cerebrospinalis-Filtration.